HomeAdvocacy Advocacy News

Advocacy News

Displaying results 1-10 (of 191)
 |<  < 1 2 3 4 5 6 7 8 9 10  >  >| 

Wisconsin Step Therapy Reform a Coalition Effort

CSRO, in partnership with the Wisconsin Step Therapy Coalition is taking the lead on step therapy reform in the state.

READ MORE

CSRO’s Dr. Robert Levin Discusses Drug Pricing in the U.S.

CSRO Board Member, Robert Levin, participated in the Healthcare Policy podcast on February 18 to discuss federal prescription drug pricing reform. In his capacity as a practicing physician, and president the Alliance for Transparent and Affordable Prescriptions, Dr. Levin provided expert testimony on drug pricing reform proposals and how the drug supply chain works.

READ MORE

The CSRO Holds Fellows Conference with Record Attendance

On February 9, 2019, the CSRO held its annual Fellows Conference in San Francisco, complete with a number of presentations on topics that surround today’s Rheumatologist.

READ MORE

Indiana Demands Policy Against Forced Medication Switches

Non-medical switching is a strategy used by health plans to reduce expenses by switching the prescription for a stable patient to a “preferred” drug — for reasons unrelated to the patients’ well-being and in some cases without warning.

READ MORE

Illinois Non-Medical Switching Law in Effect

A new law in Illinois ensures that commercial health plans deliver on policies they market and sell to Illinoisans. Prior to January 1st of this year, insurers in Illinois could change prescription drug coverage on a patient at any point during the year, and while patients were still locked into their plan. This practice is referred to as “non-medical switching” and can have serious negative health effects for patients.

READ MORE

PBMs and New Approaches to Drug Pricing in 2019

Without a doubt, lowering list-prices for prescription drugs was a national focus in 2018. Coupled with numerous advocacy organizations bringing increased awareness to Pharmacy Benefit Managers’ (PBMs) unfair practices, and their effect on drug prices, several reforms have sparked across the U.S. and are expected to increase in intensity in 2019.

READ MORE

CSRO Policy Update, January 2019, Issue 8

As the new year begins, I would like to reflect on the tremendous organizational successes that CSRO achieved in 2018. Over the past couple of years, CSRO made a commitment to deepening its ties with the societies it represents, and its allied patient and provider organizations. This year CSRO traveled to 20 state society meetings to bring increased awareness to the issues impacting practicing rheumatologists and patients in the U.S.

READ MORE

CSRO Submits IPI Comments

Prior to commenting on the proposed International Pricing Index Model (IPI) for Part B drugs, CSRO leadership met with Centers for Medicare and Medicaid Services (CMS) Administrator Seema Verma to convey rheumatology's perspective.

READ MORE

CSRO Talks Accumulator Adjustment Programs at CBI Summit

Accumulator Adjustment Programs have become an increasingly prevalent issue since CSRO was first made aware of them in late 2017. Since then, the programs have been progressively crossing over from the employer to commercial space.

READ MORE

Hospitals Beginning To Practice Non-Medical Switching

CSRO has been fielding reports from physicians around the states who have found that their patients are no longer able to access their prescribed treatment. Some hospital systems are no longer carrying biologic originator products, meaning that patients must find an alternative site of care.

READ MORE

Displaying results 1-10 (of 191)
 |<  < 1 2 3 4 5 6 7 8 9 10  >  >|